The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
This is a $169,474.83 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which has a period of performance through March 31, 2027, is not designated as a set-aside. Roche Diagnostics holds multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket...
This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...
This is a $84,784.03 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is not set aside and is for the delivery of ROCHE LAB SUPPLIES. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various...
This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...
The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $165,500 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will provide ROCHE COBAS 5800 laboratory equipment to the CDC in Castleton, Indiana by mid-November 2023. The CDC is a leading public health agency, and this equipment will likely support its efforts to advance health equity and combat infectious diseases through laboratory testing and...